GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Getting a drug from initial target discovery to U.S. regulatory approval takes between 10 and 15 years on average. Most of ...

OpenAI has unveiled GPT‑Rosalind, a new AI model focused on life sciences research. Named after Rosalind Franklin, the model ...

Trusted Answer Search is a new offering from Oracle that prioritizes control, auditability, and predictable outcomes over ...

OpenAI have announced the early release of its new AI-powered life sciences application GPT-Rosalind to specific life science groups.

Explore Perplexity AI’s features, pricing, models, and tools. Learn how this answer engine blends real-time search with AI to ...

Tempo's Zones Heighten Privacy Scrutiny Across Crypto Networks. Tempo is rolling out a new feature called Zones, a ...

OpenAI's GPT-Rosalind targets biology labs with AI trained on 50 workflows for protein analysis and drug discovery, competing ...

For companies, this creates both urgency and opportunity: organisations that adopt AI will have better audit defences, faster ...

A new partnership between NanoCo and Vercel is tackling one of the most under-discussed bottlenecks in artificial intelligence: trust. As AI agents gain access to increasingly sensitive systems like ...

A sweeping international law-enforcement campaign has disrupted one of the cybercrime market’s most accessible attack models, ...

A study on visual language models explores how shared semantic frameworks improve image–text understanding across ...